Tag: biomedical
-
A.I. System Developed to Design Entirely New Drugs
A bioinformatics team developed a system combining machine learning and neural networks with large-scale databases to design entirely new drug molecules that meet desired chemical properties and biological activity.
-
Trial Shows Antibiotic More Effective Against Crohn’s Disease
Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo.
-
Technique Assessed for Comparing Effectiveness Between Drugs
An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials.
-
NIH Small Business Grant Funds Severe Hepatitis Treatment
A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus.
-
Lyme Disease Reported Increasing, Spreading in U.S.
A medical diagnostics company released a report today showing the number of cases of Lyme disease is increasing over the past 8 years, and spreading to more parts of the U.S.
-
Infographic – U.S. Smoking Rate Hits New Low
These data show fewer than 1 in 6 Americans, or 16 percent, smoked a cigarette in the past week.
-
Scientific Reasons Doctors Are Correct (Most Of The Time)
To put it into perspective, here are the secrets to physicians’ success. These are the reasons why they are correct most of the time.
-
Challenges Seek Solutions for Chronic Diseases, Oral Drugs in Animals
Two new crowdsourcing competitions announced this week are seeking ideas on broadening the scope of drugs being developed for companion animals, and making drugs easier to give to pets and farm animals.
-
Drug Discovery System Designed to Identify Difficult Targets
A lab in the U.K. developed a system for discovering new therapies that identify therapy targets linked to enzymes, some found in neurodegenerative diseases, previously considered too difficult to address.
-
Experimental Drug Extends Survival, Reverses Inherited ALS Damage
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage.